McKesson Ventures, Novartis Venture Fund and Merck Global Health Innovation Fund took part in a round for biomarker developer Koneska.

University of Milan spinout Wise is a developer of low-invasive neuromodulation implants for treating pain and neurological disorders.

Sophia Genetics has added Hitachi to its list of shareholders following a $110m series F round that also included returning backer Swisscom.

The insurance provider has committed $100m to the Life Science Impact Program, which is managed by Grove Street Advisors and will focus on healthcare businesses.

Lyell Immunopharma was joined by new corporate backers Lilly Asia Ventures Biosciences and Alexandria Venture Investments to bring Sonoma’s series A round to $70m.

The insurer has put $54m into a corporate venturing arm called SwissHealth Ventures to target digital health startups.

Three Pulsalys businesses in healthcare and consumer feature in the first intake, run in partnership with local incubator Les Premières Aura.

The Biohaven spinoff has picked up $60m in its series A round as it expects to increase its headcount tenfold.

Sinopharm Capital chipped in for a series B round aimed at expanding MEDx's precision healthcare operation.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.